Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

SU‐DD‐A3‐04: Strategies for Respiratory‐Compensated Treatment of Lung Lesions

View through CrossRef
Purpose: The CyberKnife Synchrony system allows respiratory motion compensated treatment of lung lesions implanted with fiducials, using a model of the relative motion of the fiducials and infrared diodes on the chest. Often implantation of fiducials in the lesion is not feasible because of the potential for pneumothorax. We compare the following two alternative strategies1. Synchrony treatment with fiducials in the anterior chest wall2. Non‐Synchrony treatment with fiducials in the posterior chest wallMethod and Materials: The lung lesion patients were scanned using a GE Lightspeed Multi‐Slice scanner to obtain 300 1.25mm thick slices through the area of interest during one breath‐hold. This was performed three times covering full inspiration, full expiration, and mid‐inspiration. Fiducials were implanted percutaneously in the anterior and posterior chest wall. The lesion and position of the fiducials were delineated on all three sets of CT scans. If the motion of the lesion tracked the motion of the anterior chest wall fiducials, then a Synchrony plan was developed to treat the lesion as drawn on the mid‐inspiration CT scan. If the lesion motion did not track with the anterior chest wall fiducials then a non‐Synchrony plan was developed that treated the lesion as seen on all three sets of CT scans using the fiducials in the posterior chest wall for tracking. Results: Using anterior chest wall fiducials, the lesion motion tracked to within 1–2mm in X and Y, and 5–6mm in Z. The target was extended in Z to accommodate this. For non‐Synchrony treatments the target volumes increased by 60 to 75% and the prescription isodose volumes increased by 65 to 90%. Conclusion: The treatment of lung lesions presents a difficult challenge especially if fiducials cannot be implanted in the lesion to allow full Synchrony treatment, but the techniques described will still allow treatment.
Title: SU‐DD‐A3‐04: Strategies for Respiratory‐Compensated Treatment of Lung Lesions
Description:
Purpose: The CyberKnife Synchrony system allows respiratory motion compensated treatment of lung lesions implanted with fiducials, using a model of the relative motion of the fiducials and infrared diodes on the chest.
Often implantation of fiducials in the lesion is not feasible because of the potential for pneumothorax.
We compare the following two alternative strategies1.
Synchrony treatment with fiducials in the anterior chest wall2.
Non‐Synchrony treatment with fiducials in the posterior chest wallMethod and Materials: The lung lesion patients were scanned using a GE Lightspeed Multi‐Slice scanner to obtain 300 1.
25mm thick slices through the area of interest during one breath‐hold.
This was performed three times covering full inspiration, full expiration, and mid‐inspiration.
Fiducials were implanted percutaneously in the anterior and posterior chest wall.
The lesion and position of the fiducials were delineated on all three sets of CT scans.
If the motion of the lesion tracked the motion of the anterior chest wall fiducials, then a Synchrony plan was developed to treat the lesion as drawn on the mid‐inspiration CT scan.
If the lesion motion did not track with the anterior chest wall fiducials then a non‐Synchrony plan was developed that treated the lesion as seen on all three sets of CT scans using the fiducials in the posterior chest wall for tracking.
Results: Using anterior chest wall fiducials, the lesion motion tracked to within 1–2mm in X and Y, and 5–6mm in Z.
The target was extended in Z to accommodate this.
For non‐Synchrony treatments the target volumes increased by 60 to 75% and the prescription isodose volumes increased by 65 to 90%.
Conclusion: The treatment of lung lesions presents a difficult challenge especially if fiducials cannot be implanted in the lesion to allow full Synchrony treatment, but the techniques described will still allow treatment.

Related Results

Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Understanding cystic lung lesions in smokers with interstitial lung disease: radiologic–pathological correlation
Understanding cystic lung lesions in smokers with interstitial lung disease: radiologic–pathological correlation
Abstract Due to destructive, fibrotic, and remodeling mechanisms, we can find a varied constellation of aerated and cystic lung lesions in smoker patients with intersti...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract Introduction: In the past decade, advances in genetics have led to the discovery of numerous lung cancer susceptibility variants. The majority of these vari...

Back to Top